Cisplatin, doxorubicin, cyclophosphamide, and etoposide combination chemotherapy for small-cell lung cancer
- 1 November 1992
- journal article
- clinical trial
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 29 (6) , 435-438
- https://doi.org/10.1007/bf00684843
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Cisplatin for small-cell lung cancer.1989
- Phase II study of an intensive combination chemotherapy with cisplatin, adriamycin, etoposide and cyclophosphamide (CAVE) in small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- High-dose induction chemotherapy with cyclophosphamide, etoposide, and cisplatin for extensive-stage small-cell lung cancer.Journal of Clinical Oncology, 1987
- Doxorubicin, cyclophosphamide, etoposide and platinum, doxorubicin, cyclophosphamide and etoposide for small-cell carcinoma of the lung.1986
- Role of chemotherapy in small cell lung cancer: a consensus report of the International Association for the Study of Lung Cancer workshop.1983
- Isolated Pleural Effusion in Small Cell Lung Carcinoma: Favorable PrognosisChest, 1982
- COMBINATION CHEMOTHERAPY FOR SMALL CELL-CARCINOMA OF THE LUNG - CONTINUOUS VERSUS ALTERNATING NON-CROSS-RESISTANT COMBINATIONS1982
- cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.1979
- Small-Cell Lung CancerNew England Journal of Medicine, 1979
- SMALL CELL BRONCHOGENIC CARCINOMA - DISTINCT CLINICOPATHOLOGIC ENTITY1978